1 |
赛雪,何兴,潘卫庆, 等. 肝星状细胞与血吸虫病肝纤维化[J]. 国际医学寄生虫病杂志,2013,40(3):159-161 .
|
2 |
孙文,李军. 血吸虫性阑尾炎825例的临床分析[J]. 中华普通外科杂志,2008,23(4):305-306.
|
3 |
周文辉,杨智云,吴文泽, 等. 脑血吸虫病的CT和MRI诊断[J]. 中国CT和MRI杂志,2004,2(2):8-11.
|
4 |
Xu Y, Wang L, He J, et al. Prevalence and control of diabetes in Chinese adults[J]. JAMA,2013,310(9):948-959.
|
5 |
Diabcare-Asia中国工作组. 亚洲糖尿病治疗现状调查1998, 2001及2003年中国区结果介绍[J]. 国外医学·内分泌学分册,2005,25(3):174-178.
|
6 |
阮晓楠,周先锋,于思雨, 等. 上海市某社区3年糖尿病累积发病及其影响因素分析[J]. 中华内分泌代谢杂志,2015,31(10):856-859.
|
7 |
别文涛,郑增旺,袁梅枝. 2011年荆州市血吸虫病疫情监测[J]. 中国血吸虫病防治杂志,2013,25(6):652-654.
|
8 |
黄亚. 2004-2013年松滋市新江口镇血吸虫病疫情分析[J]. 中国血吸虫病防治杂志,2014,26(2):219-220.
|
9 |
Chen Y, Lu J, Ning G, et al. Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China[J]. Clin Endocrinol Metab,2013,98(2):E283-E287.
|
10 |
Shen SW, Lu Y, Li F, et al.The potential long-term effect of previous schistosome infection reduces the risk of metabolic syndrome among Chinese men[J]. Parasite Immunol,2015,37(7):333-339.
|
11 |
Ussaarts L, García-Tardón N, van Beek L, et al. Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice[J]. FASEB J,2015,29(7):3027-3039.
|
12 |
Han Q, Hong Y, Fu Z, et al. Characterization of VAMP2 in schistosoma japonicum and the evaluation of protective efficacy induced by recombinant SjVAMP2 in mice[J]. PLoS One,2015,10(12):e0144584.
|
13 |
Al-Olayan EM, El-Khadragy MF, Alajmi RA, et al. Ceratonia siliqua pod extract ameliorates Schistosoma mansoni-induced liver fibrosis and oxidative stress[J]. BMC Complement Altern Med,2016,16(1):434
|
14 |
Honeycutt J, Hammam O, Hsieh MH, et al. Controversies and challenges in research on urogenital schistosomiasis-associated bladder cancer[J]. Trends Parasitol,2014,30(7):324-332.
|
15 |
McDonald EA, Cheng L, Jarilla B, et al. Maternal infection with Schistosoma japonicum induces a profibrotic response in neonates[J]. Infect Immun,2014,82(1):350-355.
|
16 |
Shen SW, Lu Y, Tong DX, et al. The potential long-term effect of previous schistosome infection may reduce the risk factors for cardiovascular diseases[J]. Int J Cardiol,2014,177(2):566-568.
|
17 |
Janssen L, Silva Santos GL, Muller HS, et al. Schistosome-derived molecules as modulating actors of the immune system and promising candidates to treat autoimmune and inflammatory diseases[J]. J Immunol Res,2016,2016:5267485.
|
18 |
Schwartz C, Oeser K, Voehringer D, et al. T cell-derived IL-4/IL-13 protects mice against fatal schistosoma mansoni infection independently of basophils[J]. Immunol,2014,193(7):3590-3599.
|
19 |
Sombetzki M, Koslowski N, Doss S, et al. Biosensor for hepatocellular injury corresponds to experimental scoring of hepatosplenic schistosomiasis in mice[J]. Biomed Res Int,2016,2016:1567254
|
20 |
Lundy SK, Lukacs NW. Chronic schistosome infection leads to modulation of granuloma formation and systemic immune suppression[J]. Front Immunol,2013,4:39.
|
21 |
Santos Pd, Lorena VM, Fernandes Éde S. et al. Gestation and breastfeeding in schistosomotic mothers differently modulate the immune response of adult offspring to postnatal schistosoma mansoni infection[J]. Mem Inst Oswaldo Cruz,2016,111(2):83-92.
|